secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001493152-24-024726
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim shareholders approve reverse stock split, authorized share increase, and equity plan expansion
--------------------------------------------------------------------------------

- Approved reverse stock split at ratio of 1-for-2 to 1-for-15, at Board discretion, within one year.
- Approved increase in authorized common stock from 100M to 200M shares, at Board discretion within one year.
- Approved amendment to 2019 Equity Incentive Plan adding 3,000,000 shares for issuance.
- Stockholders did NOT approve proposal to limit officer liability under Delaware law.
- Re-elected five directors and ratified Moss Adams as independent auditor for FY2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315224024726/0001493152-24-024726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315224024726/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer